NEXIUMI.V. (AstraZeneca Pharmaceuticals LP)


Welcome to the PulseAid listing for the NEXIUM drug offered from AstraZeneca Pharmaceuticals LP. This Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA],Cytochrome P450 2C19 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: AstraZeneca Pharmaceuticals LP
NON-PROPRIETARY NAME: Esomeprazole sodium
SUBSTANCE NAME: ESOMEPRAZOLE SODIUM
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA],Cytochrome P450 2C19 Inhibitors [MoA]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2005-05-03
END MARKETING DATE: 0000-00-00


NEXIUM I.V. HUMAN PRESCRIPTION DRUG Details:

Item DescriptionNEXIUM I.V. from AstraZeneca Pharmaceuticals LP
LABELER NAME: AstraZeneca Pharmaceuticals LP
DEA SCHEDULE:
ACTIVE STRENGTH: 20(mg/5mL)
START MARKETING DATE: 2005-05-03
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0186-6020_d8c73701-98e2-4ad4-9103-7cdbad12a852
PRODUCT NDC: 0186-6020
APPLICATION NUMBER: NDA021689

Other ESOMEPRAZOLE SODIUM Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Accord Healthcare Inc.Esomeprazole sodium
Akorn, Inc.Esomeprazole Sodium
AstraZeneca Pharmaceuticals LPNEXIUM
AuroMedics Pharma LLCEsomeprazole Sodium
Cardinal HealthNEXIUM
Sun Pharma Global FZEEsomeprazole Sodium
Sun Pharmaceutical Industries LimitedEsomeprazole Sodium